D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1.
S
S
Brenner
V
V
Ruocco
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001323:Autoantibodies / Q000032:analysis*; D001324:Autoantigens / Q000276:immunology*; D015820:Cadherins / Q000276:immunology*; D051183:Desmoglein 1; D004347:Drug Interactions; D005260:Female; D006801:Humans; D009543:Nifedipine / Q000627:therapeutic use; D010392:Pemphigus / Q000139:chemically induced* / Q000276:immunology; D010396:Penicillamine / Q000009:adverse effects*; D014665:Vasodilator Agents / Q000627:therapeutic use
D018501:Antirheumatic Agents; D001323:Autoantibodies; D001324:Autoantigens; D015820:Cadherins; D051183:Desmoglein 1; D014665:Vasodilator Agents; D010396:Penicillamine; D009543:Nifedipine